These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 19258226

  • 1. [Hand-foot syndrome and sorafenib].
    Milano G, Mortier L, Digue L, Desmedt E, Ravaud A.
    Bull Cancer; 2009 Feb; 96(2):191-7. PubMed ID: 19258226
    [Abstract] [Full Text] [Related]

  • 2. [Hand-foot syndrome after administration of tyrosinkinase inhibitors].
    Bednaríková D, Kocák I.
    Klin Onkol; 2010 Feb; 23(5):300-5. PubMed ID: 21061680
    [Abstract] [Full Text] [Related]

  • 3. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    Lee WJ, Lee JL, Chang SE, Lee MW, Kang YK, Choi JH, Moon KC, Koh JK.
    Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553
    [Abstract] [Full Text] [Related]

  • 4. Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.
    Yang CH, Lin WC, Chuang CK, Chang YC, Pang ST, Lin YC, Kuo TT, Hsieh JJ, Chang JW.
    Br J Dermatol; 2008 Mar; 158(3):592-6. PubMed ID: 18070211
    [Abstract] [Full Text] [Related]

  • 5. Severe sorafenib-induced hand-foot skin reaction.
    Cuesta L, Betlloch I, Toledo F, Latorre N, Monteagudo A.
    Dermatol Online J; 2011 May 15; 17(5):14. PubMed ID: 21635836
    [Abstract] [Full Text] [Related]

  • 6. Sorafenib-induced hand-foot skin reaction: a Koebner phenomenon?
    Sibaud V, Delord JP, Chevreau C.
    Target Oncol; 2009 Dec 15; 4(4):307-10. PubMed ID: 19894099
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.
    McLellan B, Kerr H.
    Dermatol Ther; 2011 Dec 15; 24(4):396-400. PubMed ID: 21910797
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.
    Lipworth AD, Robert C, Zhu AX.
    Oncology; 2009 Dec 15; 77(5):257-71. PubMed ID: 19923864
    [Abstract] [Full Text] [Related]

  • 12. Reader seeks clarification on hand-foot skin reaction.
    Clark M.
    Clin J Oncol Nurs; 2008 Jun 15; 12(3):395; author reply 395. PubMed ID: 18564457
    [No Abstract] [Full Text] [Related]

  • 13. Interstitial granulomatous drug reaction to sorafenib.
    Martínez-Morán C, Nájera L, Ruiz-Casado AI, Romero-Maté A, Espinosa P, Meseguer-Yebra C, Córdoba S, Borbujo JM.
    Arch Dermatol; 2011 Sep 15; 147(9):1118-9. PubMed ID: 21931061
    [No Abstract] [Full Text] [Related]

  • 14. Tyrosine kinase inhibitors in advanced renal cell carcinoma: the evolving treatment paradigm.
    Bukowski RM.
    Clin Genitourin Cancer; 2009 Jan 15; 7(1):9-10. PubMed ID: 19213661
    [No Abstract] [Full Text] [Related]

  • 15. Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    Lacouture ME, Wu S, Robert C, Atkins MB, Kong HH, Guitart J, Garbe C, Hauschild A, Puzanov I, Alexandrescu DT, Anderson RT, Wood L, Dutcher JP.
    Oncologist; 2008 Sep 15; 13(9):1001-11. PubMed ID: 18779536
    [Abstract] [Full Text] [Related]

  • 16. [Use of sorafenib in patients with hepatocellular or renal carcinoma].
    Rosmorduc O, Chevreau C, Dielenseger P, Ederhy S, Goldwasser F, Grange JD, Mortier L, Neidhardt-Berard ME, Robert C, Scotté F, Seitz JF.
    Gastroenterol Clin Biol; 2010 Mar 15; 34(3):161-7. PubMed ID: 20181452
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.